Amdocs Historical Cash Flow
| DOX Stock | USD 83.99 0.88 1.04% |
Analysis of Amdocs cash flow over time is an excellent tool to project Amdocs future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 699.6 M or Other Cashflows From Financing Activities of 41 M as it is a great indicator of Amdocs ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Amdocs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amdocs is a good buy for the upcoming year.
Amdocs |
About Amdocs Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Amdocs balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Amdocs's non-liquid assets can be easily converted into cash.
Amdocs Cash Flow Chart
Amdocs Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Amdocs Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Amdocs' Change In Working Capital is fairly stable compared to the past year. Begin Period Cash Flow is likely to rise to about 699.6 M in 2024, despite the fact that Change In Cash is likely to grow to (45.6 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Amdocs to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Amdocs operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Amdocs financial statement analysis. It represents the amount of money remaining after all of Amdocs operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Amdocs' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Change In Working Capital is fairly stable compared to the past year. Begin Period Cash Flow is likely to rise to about 699.6 M in 2024, despite the fact that Change In Cash is likely to grow to (45.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 227.2M | 124.4M | 143.0M | 123.3M | Dividends Paid | 186.1M | 199.5M | 229.4M | 170.3M |
Amdocs cash flow statement Correlations
Click cells to compare fundamentals
Amdocs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amdocs cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 511.6M | (274.1M) | (135.7M) | (53.3M) | (48.0M) | (45.6M) | |
| Free Cash Flow | 452.6M | 715.4M | 529.5M | 698.3M | 803.0M | 437.6M | |
| Change In Working Capital | (110.9M) | 249.1M | (79.1M) | 51.1M | 46.0M | 48.3M | |
| Begin Period Cash Flow | 471.6M | 983.2M | 709.1M | 573.4M | 659.4M | 699.6M | |
| Other Cashflows From Financing Activities | (1.7M) | (2.5M) | 64.6M | 37.6M | 43.2M | 41.0M | |
| Depreciation | 198.4M | 208.8M | 224.5M | 195.7M | 225.1M | 181.9M | |
| Other Non Cash Items | 144K | (224.1M) | (6.7M) | 3.3M | 3.0M | 3.1M | |
| Dividends Paid | 164.1M | 177.5M | 186.1M | 199.5M | 229.4M | 170.3M | |
| Capital Expenditures | 205.5M | 210.4M | 227.2M | 124.4M | 143.0M | 123.3M | |
| Total Cash From Operating Activities | 658.1M | 925.8M | 756.7M | 822.6M | 946.0M | 560.9M | |
| Net Income | 497.8M | 688.4M | 549.5M | 543.0M | 624.4M | 350.6M | |
| Total Cash From Financing Activities | 315.1M | (870.9M) | (629.9M) | (651.4M) | (586.3M) | (557.0M) | |
| End Period Cash Flow | 983.2M | 709.1M | 573.4M | 520.1M | 598.1M | 721.1M | |
| Stock Based Compensation | 42.4M | 54.2M | 71.8M | 89.7M | 103.2M | 108.3M | |
| Change To Netincome | 25.3M | 72.7M | (221.0M) | 61.2M | 55.1M | 57.9M | |
| Change To Liabilities | (97.9M) | (205.5M) | 315.9M | (106.4M) | (95.7M) | (91.0M) | |
| Sale Purchase Of Stock | (360.9M) | (680.0M) | (508.5M) | (489.5M) | (440.6M) | (462.6M) | |
| Change To Account Receivables | 134.6M | (69.1M) | (65.0M) | 3.5M | 3.1M | 3.3M | |
| Total Cashflows From Investing Activities | (86.8M) | (461.7M) | (329M) | (262.5M) | (236.3M) | (248.1M) | |
| Other Cashflows From Investing Activities | 10.3M | (6.1M) | (6.1M) | (8.5M) | (9.8M) | (10.3M) | |
| Change To Inventory | 37.1M | (32.1M) | (7.4M) | 50.8M | 45.7M | 48.0M | |
| Investments | (753K) | (258.8M) | (12.3M) | (224.5M) | (202.0M) | (191.9M) | |
| Change To Operating Activities | 31.1M | (30.7M) | (24.5M) | 76.6M | 88.1M | 92.5M |
Pair Trading with Amdocs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.Moving together with Amdocs Stock
| 0.65 | S | SentinelOne Financial Report 6th of June 2024 | PairCorr |
| 0.64 | MQ | Marqeta Sell-off Trend | PairCorr |
Moving against Amdocs Stock
| 0.83 | NN | Nextnav Acquisition Corp Financial Report 8th of May 2024 | PairCorr |
| 0.68 | EGIO | Edgio Inc Report 17th of July 2024 | PairCorr |
| 0.61 | GB | Global Blue Group | PairCorr |
| 0.51 | VERI | Veritone Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 1.74 | Earnings Share 4.68 | Revenue Per Share 41.665 | Quarterly Revenue Growth 0.05 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.